Ahmadi Yasin, Ghorbanihaghjo Amir, Argani Hassan
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
J Cardiovasc Thorac Res. 2017;9(2):64-70. doi: 10.15171/jcvtr.2017.11. Epub 2017 Jun 29.
Hydroxy-Methyl-Glutaryl-CoA reductase (HMGCR) - the main enzyme of the cholesterol biosynthesis pathway - is mostly inhibited by statins in hepatocytes. In spite of the other tissues, liver utilizes cholesterol in different ways such as the synthesis of bile acids, excretion in to the intestine and synthesis of lipoproteins. Therefore, statins theoretically alter these pathways; although, there have not been such effects. In this review, we aim to show the roles of extra-hepatic tissues, in particular intestine, adipose and cutaneous tissues in providing the cholesterol after reduction of the whole body cholesterol content by statins.
羟甲基戊二酰辅酶A还原酶(HMGCR)——胆固醇生物合成途径的主要酶——在肝细胞中大多被他汀类药物抑制。尽管存在其他组织,但肝脏以不同方式利用胆固醇,如胆汁酸的合成、排泄到肠道以及脂蛋白的合成。因此,理论上他汀类药物会改变这些途径;然而,尚未出现此类影响。在本综述中,我们旨在展示肝外组织,特别是肠道、脂肪和皮肤组织在他汀类药物降低全身胆固醇含量后提供胆固醇方面的作用。